Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.
about
Interleukin-1 in the pathogenesis and treatment of inflammatory diseasesIn vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordoniiNew insights into the dichotomous role of innate cytokines in gut homeostasis and inflammationPreventive and therapeutic euphol treatment attenuates experimental colitis in miceInflammatory bowel diseaseLessons from genetically engineered animal models XI. Novel mouse models to study pathogenic mechanisms of Crohn's disease.Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis.Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Galphai2-deficient mice.Why not treat human cancer with interleukin-1 blockade?Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta.Biological role of interleukin 1 receptor antagonist isoformsRelevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD.Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensisNovel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammationAssociation of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians.Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage.The epithelial danger signal IL-1α is a potent activator of fibroblasts and reactivator of intestinal inflammation.The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis.Mechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo.Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studiesOpposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.Anti-inflammatory Agents: Present and FutureFunctions of interleukin 1 receptor antagonist in gene knockout and overproducing mice.Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury.Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.Toll-like receptor-7 ligand Imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitisInterleukin and interleukin receptor diversity: role of alternative splicing.Mitochondria at the interface between danger signaling and metabolism: role of unfolded protein responses in chronic inflammation.Negative regulation of human mononuclear phagocyte function.Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkersThe dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation.A question of balance: ups and downs of mucosal inflammation.Neurotensin--regulated miR-133α is involved in proinflammatory signalling in human colonic epithelial cells and in experimental colitis.Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat.IL-1 stimulates intestinal myofibroblast COX gene expression and augments activation of Cl- secretion in T84 cells.IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer.Inflammasomes in the Gut Mucosal Homeostasis.
P2860
Q24606766-BC490750-5366-48E3-8665-CCEFAE331982Q24804214-6B5E300A-D1C6-49C7-8C79-8345E34A7F4CQ26823773-2939BD51-948A-4654-8AC0-88F82C8CC265Q28477758-9CADBAD9-71F2-4C41-88E2-7ACEF0629704Q29615500-A4D67666-EF92-4D79-8C1F-E647EB36C33BQ30305634-27DE99E1-FFF4-4D16-A039-4E29D10F054DQ30863549-8EABD2AA-7879-4BC2-A4FC-43709965F5BEQ33618092-1B9F0A5C-7C0C-405B-958D-B45D850ECE0BQ33788357-43DB5681-C45B-471C-8DD4-701C809A043CQ33833871-3A299BA5-E057-4177-BEE4-82413D513317Q34008216-6D010E6A-4F85-4D96-920B-AED6BEC14876Q34071296-EA5451D1-52F3-466B-BD15-72B3085693DAQ34575468-5CDCF5B1-40D4-400A-B565-E0DBCA67ABDCQ35165095-23AAA51F-AE4B-432F-9142-0027378106C0Q35191071-EC767038-CC49-4D6F-9824-DC96629E07E1Q35363077-198571A7-C55C-4B66-A191-280C6DEC6A7DQ35594688-5FD01B83-BD40-4D0A-AFA6-BFCF59CF0A26Q35669042-CCD90410-4034-4409-A4BC-A4EA8B579C14Q35749882-6D72AFAA-0736-452C-A920-BD1B289DB6F5Q36045739-445E4CF4-03C9-4282-A2D1-2015A5492E9CQ36296995-E5F02894-BF20-408C-9353-70E64E5AB5D5Q36444778-9B7879EE-7E46-4226-89DC-83AA630B5E02Q36620188-83D73489-D25A-4234-929E-1258B8F321DCQ36994761-B57DA29F-8B5B-480D-BB57-00ECD74FE598Q37118156-4BB69CCC-3906-4BE4-8A71-6CEA8C5A9C64Q37306765-9A777606-78D3-4D88-875D-F5F541920952Q37352036-80468024-29CA-430D-A7BE-DBA5163AE43FQ37378111-95055147-72E7-4459-9286-0816B0FE8931Q37426746-8F832A37-D1EE-4814-A410-87F7AF476994Q37680986-ED87F182-2653-4A2D-BD07-AFC3EF51CC90Q37970025-82F4E765-300C-4917-AE8F-A24E2BB619C2Q38076049-335FD0D3-8883-491C-8A44-7A28B76D2C88Q38083084-41BD7650-4B12-4606-8F73-B2AE9F546928Q38234947-6C45EF3D-21FC-42CE-BEFE-1F623858BB3AQ40345628-4CF263EB-A98D-4F4D-BFFD-27497DCDF4A6Q40373621-3B174CA9-4766-4702-84F6-4354DD414C8AQ40608792-F4F96EFE-3313-44C0-A586-FFC207B22857Q41161968-E59CDBDC-1358-4375-8295-D511429AB998Q41903813-158FEE0D-F7D1-48C3-9757-7FB88AD9C4E6Q41935570-B02D8C09-E40E-41BA-B521-966CF476628E
P2860
Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@ast
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@en
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@nl
type
label
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@ast
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@en
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@nl
prefLabel
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@ast
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@en
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@nl
P2093
P2860
P356
P1476
Neutralization of endogenous I ...... tion in rabbit immune colitis.
@en
P2093
F Cominelli
M Ferretti
S P Eisenberg
T T Pizarro
V Casini-Raggi
P2860
P304
P356
10.1172/JCI117345
P407
P577
1994-07-01T00:00:00Z